Stansberry Venture Value pick hints lead to an obesity drug company whose "only competition is itself"
17 Comments Read MoreArticles
What’s Lashmet’s “Hunger Switch” Stock?
Thinkolator answers: What’s Lashmet’s “Biggest Drug in the World?”
New Stansberry ad teases that "This will likely be the first ever $1 trillion drug"
17 Comments Read MoreWhat’s up with Stansberry Venture’s “Major FDA Announcement” Pitch?
Sniffing out the teased Obesity stocks from Dave Lashmet's Stansberry Venture Technology
14 Comments Read MoreFriday File: Insurance Disruption, flat Rhythm, and a falling Par
One new buy in the Real Money Portfolio this week... plus thoughts on Lemonade, Goosehead, Rythm Pharma, Lemonade, Par Technology and more...
25 Comments Read MoreWhat’s “The 20X Weight Loss Drug?” Looking into Lashmet’s New Teaser Pitch for Stansberry Venture Technology
Checking into a teased anti-obesity drug that's not yet in the "mainstream headlines"
117 Comments Read MoreWe use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.
More Info
Comments
That was pitched as the ...
Speaking of obesity drugs, RYTM has finally recovered above where i bought it....
You missed this one bravobilly, wake up! (I was wrong). Mr. Lashmet sees RYTM in the wings waiting for the stage to cle...
I don't think Lashmet mentioned RYTM this time. It was a COVID related deal in the beginning, obesity being the conditi...
I've been burned by two of his picks in the past, Rhythm Pharmaceuticals (RYTM) and Esperion Therapeutics (ESPR). Both h...
They reported some results yesterday -- a third of people in the trial experienced weight loss of 5% in three months for...
BTW, I like RYTM very much because in America every where I look, there are too many fat, yes fat people . Even Uncle Sa...
Yes, very happy I decided to hold my position on RYTM since September despite the stock falling to 20.87 only as recentl...
Travis, I bought some shares of this RYTM after I firs read this article back in Sept. 2020, on average I paid about $...
RYTM I t is a BIG winner!...
If you mean the drug EFX, I believe that’s being developed by Akero Therapeutics.I’m still sure this tease was a...
Are we sure that RYTM is the stock they were referring to? There is another company EFX Pharmaceutical that seems to f...
Yes Stansberry's newsletters often drive markets. This morning they advised selling SII after it hit a trailing stop an...
I bought RYTM in early Sept and now its way down 28%, so I am past my trailing stop. Normally I would sell all or part o...
A couple of days ago I received from Stansberry in the mail a Very Fancy promotional package stating "You're one of onl...
Cartero, As Travis, elesido, ell and other Gumshoe folks have reported, RYTM addresses ultra-rare pediatric obes...
If you go on their website and read through the details about this drug, it says it specifically targets a small group, ...
I can attest to Rythm (RYTM) being correct and available on Nasdaq. I've owned it for several months now since Ventures ...
I have to correct my last message, and I can confirm that RYTM is correct. They have also just raised the buy-up price o...
What a "story stock"! This could be huge. Stansberry sent out an email Sunday morning, 8.30.20, promoting this Obe...
You say it's not RYTM; Travis says it is RYTM. I have never heard of you before; I have a good history with Travis. Unt...
Ascentage is developing anticancer drugs, and their first US trial (Phase Ib/II) was just approved. It can't be Ascentag...
Thanks for the confirmation, Travis. I started researching the tease, narrowed it down to RYTM, then looked to your feed...
That's interesting I wonder what caused the caused the RYTM price to go from $19 to pretty much $27. Is it the gumshoe e...
I like your analysis Travis, but I am a Stansberry Alliance member and I can tell you it is not RYTM. It is a VERY TINY...
I say it is Rhythm Pharmaceuticals RYTM. I have seen his video at Dailywealth.com. Go to to Biospace.com and enter Rh...
Injections are nasty indeed. This is why I bought a few shares of Oramed (ORMP) which seems to be in final testing stag...
Thanks to Author/Editor: Dave Lashmet for reading and going through this long and tedious Stansberry stock tip/newslette...
I wish you had done this yesterday. RYTM is up 21% today....
Damn, RYTM is up almost 21% today....